Apatinib for hepatocellular carcinoma

J Cancer Res Ther. 2019;15(4):741-742. doi: 10.4103/jcrt.JCRT_400_19.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Hepatocellular / drug therapy*
  • Carcinoma, Hepatocellular / pathology
  • Chemoembolization, Therapeutic
  • Humans
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / pathology
  • Pyridines / administration & dosage
  • Pyridines / therapeutic use*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Pyridines
  • apatinib